Jefferies Maintains a Buy on Avantor (AVTR) With a $20 PT

Avantor, Inc. (NYSE:AVTR) is one of the 13 Cheap Mid-Cap Stocks to Add to Your PortfolioIn a report released on June 9, Tycho Peterson from Jefferies maintained a Buy rating on Avantor, Inc. (NYSE:AVTR) with a price target of $20.00. The company’s fiscal Q1 2025 results reflected a continued focus on cost management amid concerns about the dynamic macroenvironment, along with disciplined execution.

Is Avantor, Inc. (AVTR) The Most Undervalued Stock With Smart Money Ratings?

A team of scientists working together to develop a new lab product or process.

Net income for the quarter reached $64.5 million, while adjusted EBITDA was  $269.5 million. Avantor, Inc. (NYSE:AVTR) also reported an expansion in its cost transformation initiative and anticipates $400 million in gross run-rate savings by the end of 2027.

Avantor, Inc. (NYSE:AVTR) is a life sciences tools company that provides mission-critical services and products to the advanced technology and life sciences industries. The company’s portfolio includes education and government, biopharma, healthcare, and applied materials and advanced technologies industries.

While we acknowledge the potential of AVTR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.